{
  "id": 10963788,
  "title": "Adding Lilly’s new drug to Zepbound helped people lose up to 23% of their weight. But there were more side effects.",
  "url": "https://urgent.news/2026/09/30/adding-lillys-new-drug-to-zepbound-helped-people-lose-up-to-23-of-10963788",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-30T14:32:00.000Z",
  "source": {
    "name": "MarketWatch",
    "slug": "marketwatch",
    "url": "https://www.marketwatch.com/story/adding-lillys-new-drug-to-zepbound-helped-people-lose-up-to-23-of-their-weight-but-there-were-more-side-effects-b7b7c6c0?mod=mw_rss_topstories"
  },
  "original_language": "en",
  "account": null,
  "summary": "The company is working on an experimental amylin drug to see if it can help people lose weight and manage their diabetes — much like a GLP-1.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "MarketWatch Top",
        "title": "Adding Lilly’s new drug to Zepbound helped people lose up to 23% of their weight. But there were more side effects.",
        "url": "https://urgent.news/2026/09/30/adding-lillys-new-drug-to-zepbound-helped-people-lose-up-to-23-of",
        "published": "2026-09-30T14:32:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}